ClinicalTrials.gg
CompletedNCT00688051Updated Sep 5, 2014

Changes in Adherence After Playing "My Life With CF" Game

An interventional study of My Life with CF game in Cystic Fibrosis, sponsored by Children's Mercy Hospital Kansas City. Completed at 1 site in United States. Open to participants aged 12 Years to 21 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2014-09-05.

Sponsored by Children's Mercy Hospital Kansas City · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
12 Years to 21 Years
Sex
All
01

Study summary

Nonadherence to treatment regimes among patients with cystic fibrosis (CF) is well documented in the literature. Unfortunately, few interventions have been successful at improving adherence rates in this patient population. Within the pediatric population, specifically adolescents, attitude toward treatment directly effects adherence to treatment. Changing attitude includes making conscious decisions regarding adherence or non-adherence and should include an understanding of what outcomes will likely result from nonadherence.

This study will determine if attitudes can be enhanced and adherence to treatment regimen improved in Cystic Fibrosis (CF) adolescent patients by using a simulation game "My Life with CF" . The target population is CF patients ages 12-21 years. Attitudes will be assessed utilizing four attitude scales in CF adolescents pre and post experiencing the simulation game. In the simulation game, patients make life decisions, including CF therapy decisions, using a fictional character diagnosed with CF. The game has been designed to help players understand the long-term effects of health care choices. Data from this pilot study will assess changes in attitudes and reported changes in adherence.

Read the detailed description

Thirty patients will be enrolled in the study. These volunteer individuals will complete the Attitude Assessment Scale and Diet and Treatment form, play the game and provide demographic data. They will complete the Attitude Assessment Scales again following the game and debriefing. These individuals will complete the Attitude Assessment Scale and Diet and Treatment form a third time, one month after playing the game. Historical review indicates that enrollment for the study can be completed within 10 months after IRB approval is secured. This allows all aspects of the study to be complete within the one year time frame established by the funding agency.

Participants for this study will be identified using study inclusion / exclusion criteria Inclusion criteria are: 1) patients with a diagnosis of CF, 2) age 12 - 20 years, 3) capable of reading and conversing in English, 4) capable and willing to provide assent for study participation, and 5) presence of a parent/guardian capable of providing informed consent. Exclusion criteria are: 1) absence of a parent/guardian or unwillingness to provide permission, 2) potential participant declines to provide assent 3) the presence of a healthcare condition that does not meet infection control standards (i.e. patients with burkodalia cepacia) for participation in the small group setting necessary to play the game. Patients with MRSA will not be excluded from the study. Patients with MRSA can play the game alone, with a CMH staff member, study personnel, or sibling. All infection control measures will be followed according to hospital policy. Members of the study team have identified patients, based on inclusion criteria, who will qualify for the study. A letter will be mailed to these patients with a description of the game, study purpose, and time requirement. A follow-up phone call will be made by a member of the study team to arrange a time when the patient can play the game. Any questions related to study participation will be answered. Consent/assent will be obtained prior to filling out the paper work at the start of the game session.

When a patient is identified for study inclusion, a study investigator will explain the study to the parent/legal guardian and the child. If both these individuals express a willingness to participate, a copy of the informed consent/assent form will be given to them. After both the parent/guardian and child have read and signed the consent/assent form, a copy will be given to each of them and placed in the medical record. The original informed consent/assent form will be kept by the PI with all study materials. The study uses a convenience sampling methodology so no unique study number will be used.

3. Treatment Groups

There are no treatment groups for this study. Participants will complete an Attitude Assessment Scale and Diet and Treatment form prior to playing the game and complete the Attitude Assessment Scales immediately after the game and debriefing. The Attitude Assessment Scales and Diet and Treatment form will also be filled out again one month after playing the game. In addition, these individuals will provide self-disclosed demographic data, which will be used only to describe the study population.

4. Drugs/Devices/Experimental Intervention:

The experimental intervention includes playing the game "My Life with CF."

Each participant will complete an assessment regarding diet and treatment adherence, and attitudes toward behaviors associated with 1) belief that luck rather than effort determines what happens to a person in life, 2) belief in personal invulnerability, and 3) making life decisions without including long-term consequences. After the baseline measure has been obtained, participants will play the "My Life with CF" game. The attitude assessment scales will be repeated after the game and debriefing. The attitude assessment scales and Diet and Treatment form will be repeated one month following the game.

5. Observations and Measurements

Participants will be asked to complete the "Attitude Assessment Scales provided in Appendix B. Attitude Scales 1,2 and 3 are the attitude scales validated for the "My Life" game. Attitude scale 4 was created specifically for the "My Life with CF" game and has not been validated. Each attitude scale has 20 questions and is based on a likert-type scale with 1 strongly disagree to 5 strongly agree. The first three attitude scales focus on the three attitudes which have been shown to influence decision making during adolescence. Attitude scale number one assesses personal invulnerability, attitude scale number two assesses present versus future considerations, and attitude scale number three measures luck versus effort. Attitude scale number 4 has an equal number of questions from the above three categories which are specific to CF.

Data collection will occur through the utilization of a "My Life with CF" Case Report Form provided in Appendix C. All study participants' personal health information will be kept confidential in compliance with Federal Law and institutional guidelines. All research case report forms will be kept in Kathy Christenson's office within a secured cabinet and destroyed in accordance with policy and procedures in place regarding research data.

02

Conditions studied

  • Cystic Fibrosis

Keywords

  • Cystic Fibrosis
  • Adherence to treatment
03

In context

Cystic Fibrosis

1,605 studies on the registry are indexed under Cystic Fibrosis; 196 are open to participants now.

This study's enrollment of 30 is below the median of 36 across 1,051 interventional studies indexed under Cystic Fibrosis.

Browse Cystic Fibrosis studies →

Lead sponsor

Children's Mercy Hospital Kansas City is the lead sponsor of 210 studies on the registry; 21 are open to participants now.

Of its 18 completed or terminated interventional studies of FDA-regulated products, 14 (78%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 21 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. patients with a diagnosis of CF
  2. age 12 - 20 years
  3. capable of reading and conversing in English
  4. capable and willing to provide assent for study participation
  5. presence of a parent/guardian capable of providing informed consent

Exclusion criteria

Exclusion Criteria:

  1. absence of a parent/guardian or unwillingness to provide permission
  2. potential participant declines to provide assent
  3. the presence of a healthcare condition that does not meet infection control standards (i.e. patients with burkodalia cepacia) for participation in the small group setting necessary to play the game.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    1

    Other: My Life with CF game

Interventions

  • OtherMy Life with CF game

    Play the game My Life with CF

    Also known as: My Life with CF

06

What researchers measure

Primary outcomes

  1. To determine changes in attitude associated with playing the game "My Life with CF".

    Time frame: One month follow up

Secondary outcomes

  1. To determine changes in frequency to adherence of treatment plan, specifically related to respiratory treatments and medications, one month after playing the game "My Life with CF".

    Time frame: One month follow up

07

Study locations

1 site
  • Children's Mercy Hospital
    Kansas City, Missouri 64108, United States
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of May 2008, a primary completion of May 2009 and a completion of May 2009. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
May 28, 2008
First posted
Jun 2, 2008
Start
May 2008
Primary completionActual
May 2009
CompletionActual
May 2009
Last update
Sep 5, 2014
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 5, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00688051
Responsible party
Craig A. Friesen, MD (Pediatric Gastroenterologist, Children's Mercy Hospital Kansas City) — Principal investigator
First posted
Jun 2, 2008
Start date
May 2008
Primary completion
May 2009
Completion
May 2009
Last update
Sep 5, 2014

Study contacts

Kathy Christenson, RN CPNP
principal investigator · Children's Mercy Hospital Kansas City

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion